Global Moxifloxacin HCl Market Research Report 2016

Publisher Name :
Date: 10-Oct-2016
No. of pages: 125
Inquire Before Buying

Notes:

Production, means the output of Moxifloxacin HCl

Revenue, means the sales value of Moxifloxacin HCl

This report studies Moxifloxacin HCl in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

- Bayer

- Rivopharm

- Actavis UK

- MERCK

- Cayman

- Allergan

- Tecoland

- BOC Sciences

- Aurobindo

- NIVIKA Chemo Pharma

- Neuland

- HETERO

- Xinchang Pharmaceutical

- Jiangsu Yongda Pharmaceutical

- HEC Pharm

- Pioneer Biotech

- Second Pharma

- Chenmei

- Bodyguard Pharmaceutical

- Yutian Pharmaceutical

- Shenyang J&Health

- Easton Pharmaceutical

- Yancheng Yufeng

- YOKO

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Moxifloxacin HCl in these regions, from 2011 to 2021 (forecast), like

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on consumption, market share and growth rate of Moxifloxacin HCl in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Moxifloxacin HCl Market Research Report 2016

Table of Contents
Global Moxifloxacin HCl Market Research Report 2016
1 Moxifloxacin HCl Market Overview
1.1 Product Overview and Scope of Moxifloxacin HCl
1.2 Moxifloxacin HCl Segment by Type
1.2.1 Global Production Market Share of Moxifloxacin HCl by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Moxifloxacin HCl Segment by Application
1.3.1 Moxifloxacin HCl Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Moxifloxacin HCl Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Moxifloxacin HCl (2011-2021)
2 Global Moxifloxacin HCl Market Competition by Manufacturers
2.1 Global Moxifloxacin HCl Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 Global Moxifloxacin HCl Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Moxifloxacin HCl Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Moxifloxacin HCl Manufacturing Base Distribution, Sales Area and Product Type
2.5 Moxifloxacin HCl Market Competitive Situation and Trends
2.5.1 Moxifloxacin HCl Market Concentration Rate
2.5.2 Moxifloxacin HCl Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Moxifloxacin HCl Capacity, Production, Revenue (Value) by Region (2011-2016)
3.1 Global Moxifloxacin HCl Capacity and Market Share by Region (2011-2016)
3.2 Global Moxifloxacin HCl Production and Market Share by Region (2011-2016)
3.3 Global Moxifloxacin HCl Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
4 Global Moxifloxacin HCl Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Moxifloxacin HCl Consumption by Regions (2011-2016)
4.2 North America Moxifloxacin HCl Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Moxifloxacin HCl Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Moxifloxacin HCl Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Moxifloxacin HCl Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Moxifloxacin HCl Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Moxifloxacin HCl Production, Consumption, Export, Import by Regions (2011-2016)
5 Global Moxifloxacin HCl Production, Revenue (Value), Price Trend by Type
5.1 Global Moxifloxacin HCl Production and Market Share by Type (2011-2016)
5.2 Global Moxifloxacin HCl Revenue and Market Share by Type (2011-2016)
5.3 Global Moxifloxacin HCl Price by Type (2011-2016)
5.4 Global Moxifloxacin HCl Production Growth by Type (2011-2016)
6 Global Moxifloxacin HCl Market Analysis by Application
6.1 Global Moxifloxacin HCl Consumption and Market Share by Application (2011-2016)
6.2 Global Moxifloxacin HCl Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Moxifloxacin HCl Manufacturers Profiles/Analysis
7.1 Bayer
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Moxifloxacin HCl Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Bayer Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Rivopharm
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Moxifloxacin HCl Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Rivopharm Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Actavis UK
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Moxifloxacin HCl Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Actavis UK Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 MERCK
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Moxifloxacin HCl Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 MERCK Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Cayman
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Moxifloxacin HCl Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Cayman Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Allergan
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Moxifloxacin HCl Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Allergan Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Tecoland
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Moxifloxacin HCl Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Tecoland Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 BOC Sciences
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Moxifloxacin HCl Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 BOC Sciences Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Aurobindo
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Moxifloxacin HCl Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Aurobindo Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 NIVIKA Chemo Pharma
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Moxifloxacin HCl Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 NIVIKA Chemo Pharma Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Neuland
7.12 HETERO
7.13 Xinchang Pharmaceutical
7.14 Jiangsu Yongda Pharmaceutical
7.15 HEC Pharm
7.16 Pioneer Biotech
7.17 Second Pharma
7.18 Chenmei
7.19 Bodyguard Pharmaceutical
7.20 Yutian Pharmaceutical
7.21 Shenyang J&Health
7.22 Easton Pharmaceutical
7.23 Yancheng Yufeng
7.24 YOKO
8 Moxifloxacin HCl Manufacturing Cost Analysis
8.1 Moxifloxacin HCl Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Moxifloxacin HCl
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Moxifloxacin HCl Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Moxifloxacin HCl Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Moxifloxacin HCl Market Forecast (2016-2021)
12.1 Global Moxifloxacin HCl Capacity, Production, Revenue Forecast (2016-2021)
12.2 Global Moxifloxacin HCl Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Moxifloxacin HCl Production Forecast by Type (2016-2021)
12.4 Global Moxifloxacin HCl Consumption Forecast by Application (2016-2021)
12.5 Moxifloxacin HCl Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Moxifloxacin HCl
Figure Global Production Market Share of Moxifloxacin HCl by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Moxifloxacin HCl Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Moxifloxacin HCl Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Moxifloxacin HCl Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Moxifloxacin HCl Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Moxifloxacin HCl Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Moxifloxacin HCl Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Moxifloxacin HCl Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Moxifloxacin HCl Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Moxifloxacin HCl Capacity of Key Manufacturers (2015 and 2016)
Table Global Moxifloxacin HCl Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Moxifloxacin HCl Capacity of Key Manufacturers in 2015
Figure Global Moxifloxacin HCl Capacity of Key Manufacturers in 2016
Table Global Moxifloxacin HCl Production of Key Manufacturers (2015 and 2016)
Table Global Moxifloxacin HCl Production Share by Manufacturers (2015 and 2016)
Figure 2015 Moxifloxacin HCl Production Share by Manufacturers
Figure 2016 Moxifloxacin HCl Production Share by Manufacturers
Table Global Moxifloxacin HCl Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Moxifloxacin HCl Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Moxifloxacin HCl Revenue Share by Manufacturers
Table 2016 Global Moxifloxacin HCl Revenue Share by Manufacturers
Table Global Market Moxifloxacin HCl Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Moxifloxacin HCl Average Price of Key Manufacturers in 2015
Table Manufacturers Moxifloxacin HCl Manufacturing Base Distribution and Sales Area
Table Manufacturers Moxifloxacin HCl Product Type
Figure Moxifloxacin HCl Market Share of Top 3 Manufacturers
Figure Moxifloxacin HCl Market Share of Top 5 Manufacturers
Table Global Moxifloxacin HCl Capacity by Regions (2011-2016)
Figure Global Moxifloxacin HCl Capacity Market Share by Regions (2011-2016)
Figure Global Moxifloxacin HCl Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Moxifloxacin HCl Capacity Market Share by Regions
Table Global Moxifloxacin HCl Production by Regions (2011-2016)
Figure Global Moxifloxacin HCl Production and Market Share by Regions (2011-2016)
Figure Global Moxifloxacin HCl Production Market Share by Regions (2011-2016)
Figure 2015 Global Moxifloxacin HCl Production Market Share by Regions
Table Global Moxifloxacin HCl Revenue by Regions (2011-2016)
Table Global Moxifloxacin HCl Revenue Market Share by Regions (2011-2016)
Table 2015 Global Moxifloxacin HCl Revenue Market Share by Regions
Table Global Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table China Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table India Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Moxifloxacin HCl Consumption Market by Regions (2011-2016)
Table Global Moxifloxacin HCl Consumption Market Share by Regions (2011-2016)
Figure Global Moxifloxacin HCl Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Moxifloxacin HCl Consumption Market Share by Regions
Table North America Moxifloxacin HCl Production, Consumption, Import & Export (2011-2016)
Table Europe Moxifloxacin HCl Production, Consumption, Import & Export (2011-2016)
Table China Moxifloxacin HCl Production, Consumption, Import & Export (2011-2016)
Table Japan Moxifloxacin HCl Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Moxifloxacin HCl Production, Consumption, Import & Export (2011-2016)
Table India Moxifloxacin HCl Production, Consumption, Import & Export (2011-2016)
Table Global Moxifloxacin HCl Production by Type (2011-2016)
Table Global Moxifloxacin HCl Production Share by Type (2011-2016)
Figure Production Market Share of Moxifloxacin HCl by Type (2011-2016)
Figure 2015 Production Market Share of Moxifloxacin HCl by Type
Table Global Moxifloxacin HCl Revenue by Type (2011-2016)
Table Global Moxifloxacin HCl Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Moxifloxacin HCl by Type (2011-2016)
Figure 2015 Revenue Market Share of Moxifloxacin HCl by Type
Table Global Moxifloxacin HCl Price by Type (2011-2016)
Figure Global Moxifloxacin HCl Production Growth by Type (2011-2016)
Table Global Moxifloxacin HCl Consumption by Application (2011-2016)
Table Global Moxifloxacin HCl Consumption Market Share by Application (2011-2016)
Figure Global Moxifloxacin HCl Consumption Market Share by Application in 2015
Table Global Moxifloxacin HCl Consumption Growth Rate by Application (2011-2016)
Figure Global Moxifloxacin HCl Consumption Growth Rate by Application (2011-2016)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Moxifloxacin HCl Market Share (2011-2016)
Table Rivopharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Rivopharm Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Rivopharm Moxifloxacin HCl Market Share (2011-2016)
Table Actavis UK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actavis UK Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Actavis UK Moxifloxacin HCl Market Share (2011-2016)
Table MERCK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MERCK Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure MERCK Moxifloxacin HCl Market Share (2011-2016)
Table Cayman Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cayman Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Cayman Moxifloxacin HCl Market Share (2011-2016)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Moxifloxacin HCl Market Share (2011-2016)
Table Tecoland Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tecoland Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Tecoland Moxifloxacin HCl Market Share (2011-2016)
Table BOC Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BOC Sciences Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure BOC Sciences Moxifloxacin HCl Market Share (2011-2016)
Table Aurobindo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aurobindo Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Aurobindo Moxifloxacin HCl Market Share (2011-2016)
Table NIVIKA Chemo Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NIVIKA Chemo Pharma Moxifloxacin HCl Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure NIVIKA Chemo Pharma Moxifloxacin HCl Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Moxifloxacin HCl
Figure Manufacturing Process Analysis of Moxifloxacin HCl
Figure Moxifloxacin HCl Industrial Chain Analysis
Table Raw Materials Sources of Moxifloxacin HCl Major Manufacturers in 2015
Table Major Buyers of Moxifloxacin HCl
Table Distributors/Traders List
Figure Global Moxifloxacin HCl Capacity, Production and Growth Rate Forecast (2016-2021)
Figure Global Moxifloxacin HCl Revenue and Growth Rate Forecast (2016-2021)
Table Global Moxifloxacin HCl Production Forecast by Regions (2016-2021)
Table Global Moxifloxacin HCl Consumption Forecast by Regions (2016-2021)
Table Global Moxifloxacin HCl Production Forecast by Type (2016-2021)
Table Global Moxifloxacin HCl Consumption Forecast by Application (2016-2021)
  • Therapies for Resistant and Recurrent Metastatic Cancer
    Published: 06-Nov-2017        Price: US 4950 Onwards        Pages: 338
    The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022. The lung cancer market is expected to grow from $15.7 billion in 2017 to $22.6 billion in 2022 at a CAGR of 7.6% for the period 2017-2022. The stomach cancer segment of the global cancer therapeutics market is expected to grow from $8.2 billion in 2017 to $11.9 billion in 2022 at a CAGR of 7.7% for the period 2017-20......
  • Healthcare Analytics: Technologies and Global Markets
    Published: 31-Oct-2017        Price: US 4950 Onwards        Pages: 105
    The global market for healthcare analytics reached $6.2 billion in 2016. This market should reach nearly $7.2 billion in 2017 and $14.9 billion by 2022, at a compound annual growth rate (CAGR) of 15.8%. The financial analytics market segment is projected to grow from $3.0 billion in 2017 to nearly $5.3 billion in 2020 at a CAGR of 11.9% for the period 2017-2022. The clinical analytics market segment is expected to grow from nearly $2.8 billion in 2017 to $6.2 billion by 2022, incre......
  • Medication Adherence: Systems, Technologies and Global Markets
    Published: 09-Oct-2017        Price: US 4950 Onwards        Pages: 166
    The global market for medication adherence reached $1.7 billion in 2016 and should reach nearly $4.0 billion by 2021 at a compound annual growth rate (CAGR) of 18.0% from 2016 through 2021. United States market for medication adherence is expected to grow from $954 million in 2016 to nearly $2.1 billion at a CAGR of 17.5% from 2016 through 2021. Asia market for medication adherence is expected to grow from $225 million in 2016 to $555 million in 2021 at a CAGR of 19.8% from 2016 th......
  • Biologic and Medical Imaging Reagents: Global Markets
    Published: 05-Oct-2017        Price: US 4950 Onwards        Pages: 286
    The global market for biological imaging reagents was valued at $13.2 billion in 2016. This market will grow from $14.4 billion in 2017 to nearly $23.9 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the period of 2017-2022. The radioactive imaging market will grow from $4.2 billion in 2017 to nearly $8.4 billion by 2022 with a CAGR of 14.7%. The optical imaging market will grow from $4.9 billion in 2017 to around $7.9 billion by 2022 with a CAGR of 9.8%.......
  • Nanotechnology in Medical Applications: The Global Market
    Published: 29-Sep-2017        Price: US 4950 Onwards        Pages: 121
    The global nanomedical market was valued at $134.4 billion in 2016. This market is projected to grow at a compound annual growth rate (CAGR) of 14.0% from 2017 through 2022 and should reach $293.1 billion by 2022 from $151.9 billion in 2017. Nanomedicine market for anticancers is projected to grow at a CAGR of 12.3% from 2017 to 2022, and should reach $84.4 billion by 2022 from $47.3 billion in 2017. Nanomedicine market for CNS products is projected to grow at a CAGR of 18.2% and s......
  • Medical Device Security: Technologies and Global Markets
    Published: 27-Sep-2017        Price: US 5500 Onwards        Pages: 140
    The global market for medical device security totaled $4.7 billion in 2016. The market should total $5.2 billion in 2017 and $7.5 billion by 2022, increasing at a compound annual growth rate (CAGR) 7.4% from 2017 to 2022. The hardware segment market for medical device security totaled $2.8 billion in 2016. The market should total over $3.0 billion in 2017 and $4.2 billion by 2022, increasing at a CAGR of 6.7% from 2017 to 2022. The software segment market for medical device securit......
  • Disposable Medical Sensors: Technologies and Global Markets
    Published: 13-Sep-2017        Price: US 4950 Onwards        Pages: 147
    The global market for disposable medical sensors reached $5.1 billion in 2016. The market should reach $5.6 billion in 2017 and $9.0 billion by 2022, at a five-year compound annual growth rate (CAGR) of 10.0% from 2017 to 2022. The North American disposable medical sensors market should reach $2.0 billion in 2017 and $3.1 billion by 2022, at a CAGR of 8.7% from 2017 to 2022. Asia-Pacific market for disposable medical sensors totaled nearly $1.5 billion in 2017 and $2.5 billion by 2......
  • Global and Chinese Dopamine Agonist Industry, 2017 Market Research Report
    Published: 04-Sep-2017        Price: US 3000 Onwards        Pages: 137
    The 'Global and Chinese Dopamine Agonist Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Dopamine Agonist industry with a focus on the Chinese market. The report provides key statistics on the market status of the Dopamine Agonist manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its def......
  • Substance Abuse, Addiction, and Treatment: Global Markets
    Published: 31-Aug-2017        Price: US 3950 Onwards        Pages: 150
    The global substance abuse and addiction treatment market reached $3.1 billion in 2016 and should reach nearly $4.4 billion in 2021, at a compound annual growth rate (CAGR) of 7.0%. The drug abuse segment reached nearly $2.3 billion in 2016 and should reach $3.1 billion by 2021, at a CAGR of 6.8%. Nicotine abuse segment reached $758 million in 2016 and should reach nearly $1.1 billion by 2021, at a CAGR of 7.3%. Companies Mentioned Alkermes Plc ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs